NewBiologix
Switzerland-based technology company developing a proprietary platform focused on engineering cell lines used to manufacture gene and cell therapies
Lausanne, Switzerlandwww.newbiologix.com ↗
Total raised
€46M
€45,804,492
Funding rounds
1
Investors
3
distinct backers
Active since
2023-05
latest 2023-05
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-11 | Series A | €46M | Igor Fish,Nicolas Mermod,Recipharm | View deal → |
Investors
3Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy